FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367338506> ?p ?o ?g. }

• W4367338506 endingPage "204062072311682" @default.
• W4367338506 startingPage "204062072311682" @default.
• W4367338506 abstract "Chimeric antigen receptor T-cell (CAR-T) cell therapies have been claimed to be curative in responsive patients. Nonetheless, response rates can vary according to different characteristics, and these therapies are associated with important adverse events such as cytokine release syndrome, neurologic adverse events, and B-cell aplasia.This living systematic review aims to provide a timely, rigorous, and continuously updated synthesis of the evidence available on the role of CAR-T therapy for the treatment of patients with hematologic malignancies.A systematic review with meta-analysis of randomized controlled trials (RCTs) and comparative non-randomized studies of interventions (NRSI), evaluating the effect of CAR-T therapy versus other active treatments, hematopoietic stem cell transplantation, standard of care (SoC) or any other intervention, was performed in patients with hematologic malignancies. The primary outcome is overall survival (OS). Certainty of the evidence was determined using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.Searches were performed in the Epistemonikos database, which collates information from multiple sources to identify systematic reviews and their included primary studies, including Cochrane Database of Systematic Reviews, MEDLINE, EMBASE, CINAHL, PsycINFO, LILACS, DARE, HTA Database, Campbell database, JBI Database of Systematic Reviews and Implementation Reports, EPPI-Centre Evidence Library. A manual search was also carried out. We included the evidence published up to 1 July 2022.We included the evidence published up to 1 July 2022. We considered 139 RCTs and 1725 NRSI as potentially eligible. Two RCTs (N = 681) comparing CAR-T therapy with SoC in patients with recurrent/relapsed (R/R) B-cell lymphoma were included. RCTs did not show statistical differences in OS, serious adverse events, or total adverse events with grade ⩾ 3. Higher complete response with substantial heterogeneity [risk ratio = 1.59; 95% confidence interval (CI) = (1.30-1.93); I2 = 89%; 2 studies; 681 participants; very low certainty evidence] and higher progression-free survival [hazard ratio for progression or death = 0.49; 95% CI = (0.37-0.65); 1 study; 359 participants; moderate certainty evidence] were reported with CAR-T therapies. Nine NRSI (N = 540) in patients with T or B-cell acute lymphoblastic leukemia or R/R B-cell lymphoma were also included, providing secondary data. In general, the GRADE certainty of the evidence for main outcomes was mostly low or very low.So far, assuming important limitations in the level of certainty due to scarce and heterogenous comparative studies, CAR-T therapies have shown some benefit in terms of progression-free survival, but no overall survival, in patients with R/R B-cell lymphoma. Despite one-arm trials have already facilitated approval of CAR-T cell treatments, additional evidence from large comparative studies is still needed to better characterize the benefit-harm ratio of the use of CAR-T in a variety of patient populations with hematological malignancies.https://doi.org/10.12688/openreseurope.14390.1.10.17605/OSF.IO/V6HDX." @default.
• W4367338506 created "2023-04-30" @default.
• W4367338506 creator A5005204150 @default.
• W4367338506 creator A5013056953 @default.
• W4367338506 creator A5029690041 @default.
• W4367338506 creator A5067000131 @default.
• W4367338506 creator A5090966300 @default.
• W4367338506 date "2023-01-01" @default.
• W4367338506 modified "2023-10-18" @default.
• W4367338506 title "Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies" @default.
• W4367338506 cites W2028460943 @default.
• W4367338506 cites W2047586716 @default.
• W4367338506 cites W2531269403 @default.
• W4367338506 cites W2787301955 @default.
• W4367338506 cites W2864786814 @default.
• W4367338506 cites W2883397499 @default.
• W4367338506 cites W2903062212 @default.
• W4367338506 cites W2911451382 @default.
• W4367338506 cites W2920797960 @default.
• W4367338506 cites W2943335541 @default.
• W4367338506 cites W2956687331 @default.
• W4367338506 cites W3027181312 @default.
• W4367338506 cites W3094048574 @default.
• W4367338506 cites W3106640820 @default.
• W4367338506 cites W3108662657 @default.
• W4367338506 cites W3118615836 @default.
• W4367338506 cites W3119568042 @default.
• W4367338506 cites W3130400555 @default.
• W4367338506 cites W3131243133 @default.
• W4367338506 cites W3148729173 @default.
• W4367338506 cites W3159640892 @default.
• W4367338506 cites W3186445392 @default.
• W4367338506 cites W3195024299 @default.
• W4367338506 cites W3211391531 @default.
• W4367338506 cites W4200014243 @default.
• W4367338506 cites W4200201081 @default.
• W4367338506 cites W4205245775 @default.
• W4367338506 cites W4210532968 @default.
• W4367338506 cites W4211022385 @default.
• W4367338506 cites W4220921096 @default.
• W4367338506 cites W4280509061 @default.
• W4367338506 cites W4280600737 @default.
• W4367338506 cites W4280634967 @default.
• W4367338506 cites W4283023614 @default.
• W4367338506 cites W4283697660 @default.
• W4367338506 cites W4293124646 @default.
• W4367338506 cites W4307233037 @default.
• W4367338506 doi "https://doi.org/10.1177/20406207231168211" @default.
• W4367338506 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37138698" @default.
• W4367338506 hasPublicationYear "2023" @default.
• W4367338506 type Work @default.
• W4367338506 citedByCount "0" @default.
• W4367338506 crossrefType "journal-article" @default.
• W4367338506 hasAuthorship W4367338506A5005204150 @default.
• W4367338506 hasAuthorship W4367338506A5013056953 @default.
• W4367338506 hasAuthorship W4367338506A5029690041 @default.
• W4367338506 hasAuthorship W4367338506A5067000131 @default.
• W4367338506 hasAuthorship W4367338506A5090966300 @default.
• W4367338506 hasBestOaLocation W43673385061 @default.
• W4367338506 hasConcept C121608353 @default.
• W4367338506 hasConcept C126322002 @default.
• W4367338506 hasConcept C143998085 @default.
• W4367338506 hasConcept C168563851 @default.
• W4367338506 hasConcept C17744445 @default.
• W4367338506 hasConcept C177713679 @default.
• W4367338506 hasConcept C189708586 @default.
• W4367338506 hasConcept C197934379 @default.
• W4367338506 hasConcept C199539241 @default.
• W4367338506 hasConcept C2776478404 @default.
• W4367338506 hasConcept C2777408962 @default.
• W4367338506 hasConcept C2777701055 @default.
• W4367338506 hasConcept C2779473830 @default.
• W4367338506 hasConcept C2779549880 @default.
• W4367338506 hasConcept C2911091166 @default.
• W4367338506 hasConcept C3875195 @default.
• W4367338506 hasConcept C71924100 @default.
• W4367338506 hasConcept C95190672 @default.
• W4367338506 hasConceptScore W4367338506C121608353 @default.
• W4367338506 hasConceptScore W4367338506C126322002 @default.
• W4367338506 hasConceptScore W4367338506C143998085 @default.
• W4367338506 hasConceptScore W4367338506C168563851 @default.
• W4367338506 hasConceptScore W4367338506C17744445 @default.
• W4367338506 hasConceptScore W4367338506C177713679 @default.
• W4367338506 hasConceptScore W4367338506C189708586 @default.
• W4367338506 hasConceptScore W4367338506C197934379 @default.
• W4367338506 hasConceptScore W4367338506C199539241 @default.
• W4367338506 hasConceptScore W4367338506C2776478404 @default.
• W4367338506 hasConceptScore W4367338506C2777408962 @default.
• W4367338506 hasConceptScore W4367338506C2777701055 @default.
• W4367338506 hasConceptScore W4367338506C2779473830 @default.
• W4367338506 hasConceptScore W4367338506C2779549880 @default.
• W4367338506 hasConceptScore W4367338506C2911091166 @default.
• W4367338506 hasConceptScore W4367338506C3875195 @default.
• W4367338506 hasConceptScore W4367338506C71924100 @default.
• W4367338506 hasConceptScore W4367338506C95190672 @default.
• W4367338506 hasFunder F4320338337 @default.
• W4367338506 hasLocation W43673385061 @default.
• W4367338506 hasLocation W43673385062 @default.

• next